These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 12924042)
41. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549 [TBL] [Abstract][Full Text] [Related]
42. Isolated plexiform neurofibroma: treatment with three-dimensional conformal radiotherapy. Robertson TC; Buck DA; Schmidt-Ullrich R; Powers CN; Reiter ER Laryngoscope; 2004 Jul; 114(7):1139-42. PubMed ID: 15235336 [TBL] [Abstract][Full Text] [Related]
43. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949 [TBL] [Abstract][Full Text] [Related]
44. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785 [TBL] [Abstract][Full Text] [Related]
45. Patterns of failure in children with medulloblastoma treated with 3D conformal radiotherapy. Skowrońska-Gardas A; Chojnacka M; Morawska-Kaczyńska M; Perek D; Perek-Polnik M Radiother Oncol; 2007 Jul; 84(1):26-33. PubMed ID: 17560676 [TBL] [Abstract][Full Text] [Related]
46. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Cowan RA; McBain CA; Ryder WD; Wylie JP; Logue JP; Turner SL; Van der Voet J; Collins CD; Khoo VS; Read GR Int J Radiat Oncol Biol Phys; 2004 May; 59(1):197-207. PubMed ID: 15093917 [TBL] [Abstract][Full Text] [Related]
47. Radiation planning comparison for superficial tissue avoidance in radiotherapy for soft tissue sarcoma of the lower extremity. Griffin AM; Euler CI; Sharpe MB; Ferguson PC; Wunder JS; Bell RS; Chung PW; Catton CN; O'Sullivan B Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):847-56. PubMed ID: 17161553 [TBL] [Abstract][Full Text] [Related]
48. Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors. Thomas E; Chapet O; Kessler ML; Lawrence TS; Ten Haken RK Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):571-8. PubMed ID: 15890602 [TBL] [Abstract][Full Text] [Related]
49. Does intensity-modulated stereotactic radiotherapy achieve superior target conformity than conventional stereotactic radiotherapy in different intracranial tumours? Sharma SD; Jalali R; Phurailatpam RD; Gupta T Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):408-16. PubMed ID: 19268555 [TBL] [Abstract][Full Text] [Related]
50. [Dosimetric evaluation for three dimensional conformal, conventional, and traditional radiotherapy plans for patients with early nasopharyngeal carcinoma]. Luo W; Deng XW; Lu TX Ai Zheng; 2004 May; 23(5):605-8. PubMed ID: 15142465 [TBL] [Abstract][Full Text] [Related]
51. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma]. Wu DH; Chen LH Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921 [TBL] [Abstract][Full Text] [Related]
52. [Progress in radiotherapy and current status]. Stranzl H Wien Med Wochenschr; 2003; 153(13-14):323-6. PubMed ID: 12924109 [TBL] [Abstract][Full Text] [Related]
55. [Organization of the follow-up treatment and control of irradiated tumor patients]. LINDGREN M Radiologe; 1962 Aug; 2():309-12. PubMed ID: 14465468 [No Abstract] [Full Text] [Related]
57. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma]. Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674 [TBL] [Abstract][Full Text] [Related]
58. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478 [TBL] [Abstract][Full Text] [Related]